Literature DB >> 218435

Contrast enhanced CT scan and radionuclide brain scan in supratentorial gliomas.

A R Butler, A M Passalaqua, A Berenstein, I I Kricheff.   

Abstract

The preoperative contrast enhanced CT and radionuclide brain scans of 60 patients with surgically verified supratentorial astrocytomas were evaluated and compared. Results indicated that the mechanisms of contrast enhancement and radionuclide uptake are identical in the detection of supratentorial gliomas. These diagnostic methods apparently mirror the integrity of the blood-brain barrier and therefore can be useful in assessing the degree of malignancy of supratentorial gliomas. However, lesions with an intact blood-brain barrier will be missed with radionuclide imaging. These parenchymal abnormalities and/or the associated mass effect will be detected with contrast enhanced computed tomography. These findings firmly establish contrast enhanced computed tomography. These findings firmly establish contrast enhanced CT as the primary investigate tool in the suspected brain tumor.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218435     DOI: 10.2214/ajr.132.4.607

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

Review 1.  The role of nuclear procedures in the diagnosis of intracranial disease.

Authors:  U Büll
Journal:  Neurosurg Rev       Date:  1981       Impact factor: 3.042

2.  Postmortem MRI of the brain with neuropathological correlation.

Authors:  L van den Hauwe; P M Parizel; J J Martin; P Cras; P De Deyn; A M De Schepper
Journal:  Neuroradiology       Date:  1995-07       Impact factor: 2.804

3.  Landscape, Presentation, and Characteristics of Brain Gliomas in Zimbabwe.

Authors:  Luxwell Jokonya; Aaron Musara; Ignatius Esene; Tariro Lavender Mduluza-Jokonya; Rudo Makunike-Mutasa; Sally Rothemeyer; Kazadi Kaluile Ntenge Kalangu; Takafira Mduluza; Thajasvarie Naicker
Journal:  Asian J Neurosurg       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.